Skip to main content

New and competing renewal awards for November 2018

Friday, December 7, 2018
McGovern-Davison Children's Health Center

The following are new and competing renewal awards made to faculty in the Department of Pediatrics through the month of November 2018. Please extend your congratulations to these individuals.

Dwight D. Koeberl (Medical Genetics) received an award from Baebies Inc. in the amount of $20,710 for a study entitled “Rapid Neonatal Testing for Ammonia Disorder Biomarkers.” National Institutes of Health is a prime sponsor. The project period is 7/1/2018 – 12/31/2018.

Dwight D. Koeberl (Medical Genetics) received an award from Moderna Therapeutics Inc. in the amount of $80,032 for a study entitled “Mapping the Patient Journey in Methylmalonic and Propionic Acidemia: A Longitudinal, Exploratory, Natural History Study to Further Characterize and Describe the Signs and Symptoms of Patients with Organic Acidemias.”  The project period is 11/7/2018 – 8/31/2021.

Michelle J. White (Hospital Medicine) received an award in the amount of $9,270 from Academic Pediatric Association for a project entitled “Changes in the Recreational Built Environment and Youth BMI in Durham, NC.” The project period is 10/1/2018 – 9/30/2019.

Muhammad S. Zafar (Neurology) received an award in the amount of $230,758 from Marinus Pharmaceuticals, Inc. for a study entitled “A Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone Treatment in Children and Young Adults with Cyclin-dependent Kinase-like 5 (CDKL5) Deficiency Disorder (CDD) Followed by Long-term Open-label Treatment.” The project period is 10/30/2018 – 12/31/2022.

Muhammad S. Zafar (Neurology) received an award in the amount of $267,040 from UCB Pharma Inc. for a study entitled “A Multicenter, Open-label Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Brivaracetam in Subjects 1 Month to 16 Years of Age with Epilepsy, Phase 2.” The project period is 7/3/2018 – 11/30/2019.

Vinod K. Prasad (Blood and Marrow Transplantation) received an award in the amount of $117,120 from Magenta Therapeutics for a study entitled “A Phase 2, Single-arm, Open-label, Study to Evaluate the Safety and Efficacy of MGTA-456 in Patients with Inherited Metabolic Disorders (IMD) Undergoing Hematopoietic Stem Cell (HSC) Transplantation (HSCT).” The project period is 10/30/2018 – 9/30/2020.

Jennifer A. Rothman (Hematology-Oncology) received an award in the amount of $221,516 from Novartis Pharmaceuticals Corp. for a study entitled “A Phase 2, Multicenter, Open-Label Study to Assess Appropriate Dosing and to Evaluate Safety of Crizanlizumab, with or without Hydroxyurea/Hydroxycarbamide, in Sequential, Descending Age Groups of Pediatric Sickle Cell Disease Patients with Vaso-Occl.” The project period is 5/11/2018 – 6/1/2025.

Mai ElMallah (Pulmonary and Sleep Medicine) received an award in the amount of $13,669 from Vertex Pharmaceuticals Inc. for a study entitled “A Post-approval Observational Study to Evaluate the Long-term Effectiveness and Safety of Orkambi in US Patients who Completed Study VX12-809-105 Part A.” The project period is 6/21/2018 – 4/30/2021.

Matthew Kelly (Infectious Diseases) received an award in the amount of $138,158 from Merck Sharp & Dohme for a study entitled “A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of a Single Infusion of Bezlotoxumab (MK-6072, Human Monoclonal Antibody to C. difficile Toxin B) in Children.” The project period is 07/01/2018 - 07/31/2022.

Laura E. Schanberg (Rheumatology) received an award in the amount of $46,973 from Boston’s Children Hospital for a study entitled “Expanding HL7 FHIR to Support Post-marketing Research and Surveillance within Multi-source, Chronic Disease Registries.” Food and Drug Administration is a prime sponsor. The project period is 9/1/2018 – 8/31/2019.

Laura E. Schanberg (Rheumatology) received an award in the amount of $6,988,387 from Patient Centered Outcomes Research Institute for a study entitled “Improving Outcomes in Limited Juvenile Idiopathic Arthritis.” The project period is 9/1/2018 – 7/31/2023.

Rachel G. Greenberg (Neonatology) received an award in the amount of $494,216.40 from Canada Royal Milk ULC for a research study entitled “Infant Formula Study.”  The project period is 08/31/2018 – 11/30/2018.

Congratulations to these faculty on their awards and best wishes to them in their investigative work.

Coleen K. Cunningham, MD
Vice Chair, Research
Professor of Pediatrics
Division of Infectious Diseases
Chief, Division of Global Health